Plus Therapeutics reported $275K in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Baxter International USD 517M 549K Jun/2026
Dr.Reddys Laboratories INR 833.07M 382K Sep/2026
Haemonetics USD 45.52M 53K Sep/2026
Northwest Biotherapeutics USD 1.61B 88.6M Mar/2026
Plus Therapeutics USD 275K 138.4M Mar/2026
Sanofi EUR 1.2B 0 Sep/2026
Starpharma Holdings AUD 419.92M 179.17M Dec/2025
Sun Pharmaceuticals INR 2.4B 0 Sep/2026
Teva Pharmaceutical Industries USD 1.17B 2M Sep/2026